Most Recent Articles by Gary Rothbard MD, MS
A recent literature review and meta-analysis indicates that growth hormone therapy may reduce the risk for fracture in patients with osteoporosis.
The prevalence of sarcopenia — particularly in combination with ostepenia — increases with age, and sarcopenic obesity may be underrecognized, despite its impact in patients with rheumatic diseases.
Endocrinology Advisor Articles
- HbA1c Variability Predicts All-Cause Mortality in Type 2 Diabetes
- Nivolumab Associated With Thyroiditis in Patients With Cancer
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Metabolic Syndrome Associated With Higher ALT Levels in Chronic Hepatitis B
- April 28 Is Drug Take Back Day
- Risk for Fetal Loss Early in Pregnancy Not Greater With Noninsulin vs Insulin Therapy
- ACP: Position Paper Recommends Solutions to Close Gender Equity Gap
- Vitamin D Insufficiency Associated With Insulin Resistance Independent of Obesity in Children
- Factors Identified to Predict Fatty Liver in Obese Teens